•  
  •  
 

Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science

Specialty

Neurology

Advisor

Akya Myrie, MS4

Abstract

Numerous medications can successfully control seizures for most people with epilepsy, one of the most common neurologic disorders. Still, many patients experience uncontrollable seizures. About a third of patients continue to be pharmaco-resistant, which has resulted in the development of novel agents. Cannabis was introduced as far back as 1838, with remarkable success in treating epilepsy. In 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex® (cannabidiol), the first drug composed of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.

Restricted

Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.

Share

COinS